Targets and teamwork: Understanding differences in pediatric diabetes centers treatment outcomes

Timothy C Skinner1, Karin S Lange2, Hilary Hoey3

  • 1School of Psychological and Clinical Sciences, Charles Darwin University, Darwin, Northern Territory, Australia.

Pediatric Diabetes
|November 22, 2017
PubMed

Insights

Diabetes care teams’ shared goals and expectations influence parental targets, impacting metabolic control in children with type 1 diabetes. This study highlights the importance of team cohesion for better pediatric diabetes outcomes.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Disorders
  • Diabetes Management

Background:

  • Significant variations exist in metabolic control among pediatric diabetes centers globally.
  • The underlying reasons for these center-specific differences in outcomes remain largely undetermined.
  • Understanding these factors is crucial for improving treatment efficacy and patient care.

Purpose of the Study:

  • To investigate the extent to which healthcare professionals' targets and expectations influence center-specific differences in metabolic outcomes for children with type 1 diabetes.
  • To explore the relationship between care team perspectives, parental targets, and patient hemoglobin A1c (HbA1c) levels.
  • To identify factors contributing to disparities in pediatric diabetes care quality.

Main Methods:

  • Cross-sectional study involving 1113 children (under 11) with type 1 diabetes from 18 centers in 17 countries.
  • Data collection included clinical, demographic information, and blood samples for HbA1c assay.
  • Questionnaires assessed treatment targets and monitoring frequency for parents and healthcare professionals.

Main Results:

  • Mean HbA1c levels varied substantially across centers, from 7.3% to 8.9%.
  • Centers with lower mean HbA1c featured parents reporting lower targets, healthcare professionals reporting lower targets and more frequent testing, and greater team agreement on targets.
  • Higher team-reported HbA1c targets and target disagreement correlated with higher parental-reported targets, partially explaining center differences.

Conclusions:

  • The cohesiveness and perspectives of pediatric diabetes care teams significantly influence parental treatment targets.
  • These team dynamics contribute to observed differences in metabolic outcomes among pediatric diabetes centers.
  • Optimizing team communication and target alignment may improve pediatric diabetes care quality.
Abstract

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.1K
Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
966
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
258
Guidelines for Writing Outcome01:11

Guidelines for Writing Outcome

When developing expected outcomes for a patient care plan, the nurse should adhere to the following recommendations:
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
4.1K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
289
Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
7.2K